Discover trends, market shifts, and competitive outlooks for the chorionic gonadotropin global market report 2025 industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Chorionic Gonadotropin Market Size from 2025 to 2034?

In the past few years, there has been a consistent increase in the size of the chorionic gonadotropin market. The market is expected to grow from $1,260 million in 2024 to $1,340 million in 2025, reflecting a compound annual growth rate (CAGR) of 4.4%. The remarkable growth seen during the historical period is associated with a rise in hCG knowledge among healthcare professionals and patients, augmented usage for treating hormonal imbalance conditions, improved affordability, advancements in healthcare facilities, and escalating demand for assisted reproduction.

In the forthcoming years, it is anticipated that the chorionic gonadotropin market will experience a steady expansion. By 2029, it is projected to reach a market valuation of $1,710 million, with a compound annual growth rate (CAGR) of 4%. The growth during the predicted period is likely due to factors such as the escalating cases of infertility issues, heightened awareness regarding reproductive health, growing acceptance of assisted reproductive technologies, increasing instances of hypogonadism among the senior population, and the development of healthcare infrastructure. The forecast period is also expected to see prominent trends such as technological advancements, progress in recombinant technology, expansion in assisted reproductive technology, increased investment in research and development, and innovative improvements in drug delivery systems and pharmaceutical formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

What Are the Core Growth Drivers Propelling the Chorionic Gonadotropin Market Forward?

The surge in infertility issues is predicted to encourage the growth of the chorionic gonadotropin market in the future. Infertility is a condition wherein a couple, usually under 35 years old, fails to conceive after a year of unprotected sexual activity, or after six months for couples 35 years and older. This increasing incidence of infertility largely springs from late childbearing decisions and lifestyle factors like obesity and smoking which can adversely affect fertility. Chorionic Gonadotropin (hCG) plays a key role in fertility treatments, helping women to ovulate, ensuring pregnancy maintenance, and boosting male testosterone levels to enhance sperm count. For example, in April 2023, the World Health Organization (WHO) reported that about 17.5% of the worldwide adult population, equals to one in six people, were dealing with infertility, highlighting the critical need to better access affordable, superior fertility healthcare. Therefore, the rising prevalence of infertility is boosting the growth of the chorionic gonadotropin market. Growth in assisted reproductive technologies is propelling the chorionic gonadotropin market. Assisted reproductive technologies (ART) are medical interventions employed to help individuals or couples become pregnant when faced with natural conception difficulties. With higher infertility rates, medical advances, late childbearing, and broadened access, the demand for assisted reproductive technologies (ART) is on the rise. Chorionic gonadotropin (hCG) is used in these technologies to stimulate ovulation and fortify the luteal phase post-embryo transfer, ensuring successful fertilization and early pregnancy. For example, in April 2024, MJH Life Sciences documented an increased number of ART cycles being performed, with egg freezing cycles up from 24,560 in 2021 to 29,803 in 2022. Thus, the surge in assisted reproductive technologies is fueling the growth of the chorionic gonadotropin market.

What Segment Types Define the Chorionic Gonadotropin Market Structure?

The chorionic gonadotropinmarket covered in this report is segmented –

1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications

4) By End User: Research Institutions; Pharmaceutical Companies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19888&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Chorionic Gonadotropin Market?

North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Chorionic Gonadotropin Industry Evolution?

The chorionic gonadotropin market is primarily guided by a trend towards the development of novel solutions such as saliva-based pregnancy tests to enhance convenience, precision, and availability. The saliva-based pregnancy test is a non-invasive diagnosis technique that identifies pregnancy by scrutinizing a woman’s saliva for the existence of human chorionic gonadotropin (hCG), a hormone generated during pregnancy. For example, in June 2023, Salignostics, an Israeli biotechnological firm, introduced the first-ever saliva-based pregnancy test globally. This groundbreaking product permits women to verify pregnancy employing a saliva sample instead of urine, uncovering the hormone hCG (human chorionic gonadotropin) with results obtainable in just 5 to15 minutes. Salistick proposes a more relaxed and handy testing experience, allowing users to conduct the test whenever they prefer and share the experience with their partners or close ones.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

What Is the Definition of the Chorionic Gonadotropin Market?

Chorionic gonadotropin, specifically human chorionic gonadotropin (hCG), is a hormone produced by the placenta during pregnancy that supports the corpus luteum to maintain progesterone levels. It is used in medical treatments to induce ovulation in women, treat hypogonadism in men, and as a tumor marker for certain cancers.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model